Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Treasury Shares: 2022-2024

Historic Treasury Shares for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to $906,944.

  • Axsome Therapeutics' Treasury Shares rose 11.98% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $906,944 for FY2024, which is 12.78% up from last year.
  • According to the latest figures from FY2024, Axsome Therapeutics' Treasury Shares is $906,944, which was up 12.78% from $804,150 recorded in FY2023.
  • Axsome Therapeutics' Treasury Shares' 5-year high stood at $906,944 during FY2024, with a 5-year trough of $686,375 in FY2022.
  • Moreover, its 3-year median value for Treasury Shares was $804,150 (2023), whereas its average is $799,156.
  • Data for Axsome Therapeutics' Treasury Shares shows a peak YoY grew of 17.16% (in 2023) over the last 5 years.
  • Axsome Therapeutics' Treasury Shares (Yearly) stood at $686,375 in 2022, then rose by 17.16% to $804,150 in 2023, then increased by 12.78% to $906,944 in 2024.